232 related articles for article (PubMed ID: 1390743)
1. Three-dimensional solution structure of the B domain of staphylococcal protein A: comparisons of the solution and crystal structures.
Gouda H; Torigoe H; Saito A; Sato M; Arata Y; Shimada I
Biochemistry; 1992 Oct; 31(40):9665-72. PubMed ID: 1390743
[TBL] [Abstract][Full Text] [Related]
2. Sequential 1H NMR assignments and secondary structure of the B domain of staphylococcal protein A: structural changes between the free B domain in solution and the Fc-bound B domain in crystal.
Torigoe H; Shimada I; Saito A; Sato M; Arata Y
Biochemistry; 1990 Sep; 29(37):8787-93. PubMed ID: 2271556
[TBL] [Abstract][Full Text] [Related]
3. NMR study of the interaction between the B domain of staphylococcal protein A and the Fc portion of immunoglobulin G.
Gouda H; Shiraishi M; Takahashi H; Kato K; Torigoe H; Arata Y; Shimada I
Biochemistry; 1998 Jan; 37(1):129-36. PubMed ID: 9425032
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of binding staphylococcal protein A to immunoglobin G does not involve helix unwinding.
Jendeberg L; Tashiro M; Tejero R; Lyons BA; Uhlén M; Montelione GT; Nilsson B
Biochemistry; 1996 Jan; 35(1):22-31. PubMed ID: 8555177
[TBL] [Abstract][Full Text] [Related]
5. High-resolution solution NMR structure of the Z domain of staphylococcal protein A.
Tashiro M; Tejero R; Zimmerman DE; Celda B; Nilsson B; Montelione GT
J Mol Biol; 1997 Oct; 272(4):573-90. PubMed ID: 9325113
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of the E-domain of staphylococcal protein A.
Starovasnik MA; Skelton NJ; O'Connell MP; Kelley RF; Reilly D; Fairbrother WJ
Biochemistry; 1996 Dec; 35(48):15558-69. PubMed ID: 8952510
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of recombinant hirudin and the Lys-47----Glu mutant: a nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing study.
Folkers PJ; Clore GM; Driscoll PC; Dodt J; Köhler S; Gronenborn AM
Biochemistry; 1989 Mar; 28(6):2601-17. PubMed ID: 2567183
[TBL] [Abstract][Full Text] [Related]
8. The high-resolution, three-dimensional solution structure of human interleukin-4 determined by multidimensional heteronuclear magnetic resonance spectroscopy.
Powers R; Garrett DS; March CJ; Frieden EA; Gronenborn AM; Clore GM
Biochemistry; 1993 Jul; 32(26):6744-62. PubMed ID: 8329398
[TBL] [Abstract][Full Text] [Related]
9. Determination of the three-dimensional solution structure of the C-terminal domain of cellobiohydrolase I from Trichoderma reesei. A study using nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing.
Kraulis J; Clore GM; Nilges M; Jones TA; Pettersson G; Knowles J; Gronenborn AM
Biochemistry; 1989 Sep; 28(18):7241-57. PubMed ID: 2554967
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional structures of the amyloid beta peptide (25-35) in membrane-mimicking environment.
Kohno T; Kobayashi K; Maeda T; Sato K; Takashima A
Biochemistry; 1996 Dec; 35(50):16094-104. PubMed ID: 8973180
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional solution structure of the calcium channel antagonist omega-agatoxin IVA: consensus molecular folding of calcium channel blockers.
Kim JI; Konishi S; Iwai H; Kohno T; Gouda H; Shimada I; Sato K; Arata Y
J Mol Biol; 1995 Jul; 250(5):659-71. PubMed ID: 7623383
[TBL] [Abstract][Full Text] [Related]
12. Tertiary structure of erabutoxin b in aqueous solution as elucidated by two-dimensional nuclear magnetic resonance.
Hatanaka H; Oka M; Kohda D; Tate S; Suda A; Tamiya N; Inagaki F
J Mol Biol; 1994 Jul; 240(2):155-66. PubMed ID: 8027999
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional solution structure and backbone dynamics of a variant of human interleukin-3.
Feng Y; Klein BK; McWherter CA
J Mol Biol; 1996 Jun; 259(3):524-41. PubMed ID: 8676386
[TBL] [Abstract][Full Text] [Related]
14. High-resolution solution structure of reduced French bean plastocyanin and comparison with the crystal structure of poplar plastocyanin.
Moore JM; Lepre CA; Gippert GP; Chazin WJ; Case DA; Wright PE
J Mol Biol; 1991 Sep; 221(2):533-55. PubMed ID: 1920431
[TBL] [Abstract][Full Text] [Related]
15. Determination of the solution structure of Apo calbindin D9k by NMR spectroscopy.
Skelton NJ; Kördel J; Chazin WJ
J Mol Biol; 1995 Jun; 249(2):441-62. PubMed ID: 7783203
[TBL] [Abstract][Full Text] [Related]
16. Solution structure of the TR1C fragment of skeletal muscle troponin-C.
Findlay WA; Sönnichsen FD; Sykes BD
J Biol Chem; 1994 Mar; 269(9):6773-8. PubMed ID: 8120037
[TBL] [Abstract][Full Text] [Related]
17. NMR structure of the J-domain and the Gly/Phe-rich region of the Escherichia coli DnaJ chaperone.
Pellecchia M; Szyperski T; Wall D; Georgopoulos C; Wüthrich K
J Mol Biol; 1996 Jul; 260(2):236-50. PubMed ID: 8764403
[TBL] [Abstract][Full Text] [Related]
18. Solution conformation of thymosin beta 4: a nuclear magnetic resonance and simulated annealing study.
Zarbock J; Oschkinat H; Hannappel E; Kalbacher H; Voelter W; Holak TA
Biochemistry; 1990 Aug; 29(34):7814-21. PubMed ID: 2261438
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional structure of acyl carrier protein in solution determined by nuclear magnetic resonance and the combined use of dynamical simulated annealing and distance geometry.
Holak TA; Nilges M; Prestegard JH; Gronenborn AM; Clore GM
Eur J Biochem; 1988 Jul; 175(1):9-15. PubMed ID: 3402450
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of a human cystatin A variant, cystatin A2-98 M65L, by NMR spectroscopy. A possible role of the interactions between the N- and C-termini to maintain the inhibitory active form of cystatin A.
Tate S; Ushioda T; Utsunomiya-Tate N; Shibuya K; Ohyama Y; Nakano Y; Kaji H; Inagaki F; Samejima T; Kainosho M
Biochemistry; 1995 Nov; 34(45):14637-48. PubMed ID: 7578072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
